CSI Market
Sign In | Register

Alexion Pharmaceuticals Inc (ALXN) Annual Income Statement

Annual · GAAP · USD millions
Access ALXN quarterly income statements →
Reviewing income statement figures over time helps illustrate how Alexion Pharmaceuticals Inc generates earnings and manages operating expenses.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
2020 		(Dec 31 2019) (Dec 31 2018) (Dec 31 2017) (Dec 31 2016)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax6,069.90
Total Revenue6,069.90
Costs & Expenses
Cost of Goods and Services Sold553.50
Gross Profit5,516.40
Selling, Administration, Marketing1,399.90
Research & Development1,002.90
Business Combination, Acquisition Related Costs2,170.90
Other exp. /-income61.20
Total operating costs including COS5,437.60
Operating income / -loss632.30
Interest Expense104.70
Net Interest (-)Expense / Income-104.70
Foreign Currency Transaction Gain (Loss), before Tax0.00
Other loss/ -income-41.40
Total costs & expenses5,500.90
Income & Taxes
Income / -loss before income taxes569.00
Income taxes expenses / -benefit-34.40
Income after income taxes603.40
Net income / -loss of other equity0.00
Income / -loss from continuing operations603.40
Net income / -loss603.40
Income / -loss to shareholder603.40
EBIT673.70
EBITD1,003.10
EBITDA1,167.30
Earnings Per Share
Basic EPS (excl. extra items)2.74
Basic Net EPS2.74
Basic shares outstanding (Mill. of Units)220.10
Diluted Net EPS2.72
Diluted average shares (Mill. of Units)222.00
4 historic quarters locked

Sign in to unlock the full Alexion Pharmaceuticals Inc income statement history.

Sign In Create Free Account

About ALXN Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.